Webinar: Innovative Adjuvants for Advancing Global Health
Innovative Adjuvants for Advancing Global Health
Webinar Details
Date: September 9, 2026
Time: 6:00 AM ET
Location: Online Webinar
Register Now:
https://us06web.zoom.us/webinar/register/WN_SAlYDg_xQ0K1BympVj7evQ#/registration
What You'll Learn
Discover how innovative adjuvant systems can help address the growing demand for scalable and accessible vaccine solutions. During this session, experts from SPI Pharma and Inimmune will discuss:
- Globally licensable adjuvant platforms
- T4Q, T4QGH, T4SE, and T4AH technologies
- The role of the stable MPL analogue INI-2002
- Performance, immunogenicity, and safety considerations for next-generation vaccine adjuvants
Featured Speakers
Peter Tygesen
Business Development Director, Vaccine Adjuvants, SPI Pharma
Peter Tygesen brings more than 30 years of pharmaceutical industry experience and has spent over a decade focused on vaccine adjuvant innovation. He has played a significant role in supporting the development and commercialization of adjuvant technologies used globally.
Dr. Juhienah Khalaf
Director of Chemistry, Inimmune Corporation
Dr. Khalaf specializes in the design and development of novel vaccine adjuvants and immunomodulators, with expertise spanning medicinal chemistry, formulation, and CMC development. Her work focuses on technologies that enhance immune responses while expanding access to innovative vaccine solutions.
Who Should Attend?
This webinar is designed for:
- Vaccine developers
- Formulation scientists
- R&D leaders
- Process development teams
- CMC professionals
- Global health organizations
- Pharmaceutical and biotechnology professionals interested in vaccine innovation